Just a little quote on PTX from MorningStar via ComSec
Summary
Prescient Therapeutics Limited (PTX) is a clinical stage oncology company developing novel compounds that show potential new therapies to treat a range of cancers that have become resistant to front line chemotherapy.
"MorningstarTM Quantitative
26 Oct 2019
More details about Morning Star Quantitative
Undervalued
Fair value $0.11 Liquidity High"
Just a little quote on PTX from MorningStar via ComSec Summary...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $34.62M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.5¢ | 4.3¢ | $17.99K | 416.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 152502 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 502504 | 5 |
View Market Depth
| Last trade - 15.59pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.3¢ |
Change
-0.001 ( 4.44 %) |
||||
| Open | High | Low | Volume | ||
| 4.3¢ | 4.5¢ | 4.3¢ | 123400 | ||
| Last updated 15.57pm 17/05/2024 ? | |||||
| PTX (ASX) Chart |